Curvebeam Ai Ltd. · ASX:CVB
Curvebeam Ai — Investor Presentation (April 2025)
8 slides from Curvebeam Ai's investor presentation, Apr 30, 2025
Slide 1: Quarterly 4C Conference Call
QUARTERLY 4C CONFERENCE CALL 30th of April 2025
Slide 2: Disclaimer
DISCLAIMER Introduction THIS DOCUMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, Forward looking statements DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA OR TO ANY The information given in this presentation is given for illustrative purposes only
Slide 3: 4C Summary of Key Activities
4C SUMMARY OF KEY ACTIVITIES • During Q3 FY25, CurveBeam AI received purchase orders (POs) for seven (7) devices, four (4) of which were HiRise™. • Total POs for Q3 FY25 were up 40% from five (5) in the prior corresponding period (pcp). • Twenty (20) POs have been received for the nine (9) month per
Slide 4: Quarterly Purchase Orders Analysis
QUARTERLY PURCHASE ORDERS ANALYSIS Device Purchase Orders Q1 FY24 Q2 FY24 Q3 FY24 Q1 FY25 Q2 FY25 Q3 FY25 US 2 2 2 1 8 4 Rest of World 1 2 3 2 2 3 Total 3 4 5 3 10 7 Total Purchase Orders by Qtr 12 TM 10 8 Discontinued 6 4 2 0 Q1 FY24 Q2 FY24 Q3 FY24 Q1 FY25 Q2 FY25 Q3 FY25 US Rest of World Total ®
Slide 5: Cash Analysis
Cash Analysis • Cash at the end of Q3 was A$4.9m, with receivables plus cash due as at the end of Q3 FY25 from previous POs of A$7.9m. This is expected to result in a near-term cash position for the Company of A$13.8m. • Cash used in operations for Q3 FY25 was A$4.4m versus A$4.5m in Q3 FY24 (pcp) a
Slide 6: Enhanced HiRise Project for Robotic Aided Surgical Systems
ENHANCED HIRISE™ PROJECT FOR ROBOTIC AIDED SURGICAL SYSTEMS • CurveBeam AI has completed the development of the Enhanced HiRise™ platform and is FDA 510(k) cleared. • Enhanced HiRise™ WBCT scans, with higher energy X-Ray source, allows key anatomical landmarks to be identified in larger patients. •
Slide 7: In Closing
IN CLOSING • During Q3 FY25, CurveBeam AI received purchase orders (POs) for seven (7) devices, up 40% from five (5) in the prior corresponding period (pcp). • Twenty (20) POs have been received for the nine (9) month period to 31 March 2025 versus twelve (12) in the pcp, up 67%. • Cash at the end o
Slide 8: Definitions
DEFINITIONS CurveBeam AI’s key metrics are defined and interpreted as follows: • Purchase order – a signed purchase order (PO) for a CT scanner (device). The Company considers POs to be a key metric as it reflects actual sales at any given time. • Receipts from customers – any cash consideration rec